Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

NCT07704918 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Statins (atorvastatin, rosuvastatin, simvastatin, or pravastatin), +/- ezetimibe, +/- PCSK9 inhibitor (alirocumab, evolocumab, inclisiran)

Sponsor

University of Colorado, Denver